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        Introduction 
  Metabolic pathways are commonly regulated at key steps termed 
branchpoints, in which several key pathways diverge from a 
single precursor. Such a branchpoint occurs in the biosynthesis 
of O-glycans of animal cell glycoproteins, in which the common 
precursor to all mucin-type O-glycans, N-acetylgalactosamine 
(GalNAc)      1-Ser/Thr (Tn antigen), may be modifi  ed by one of 
several enzymes to generate different core structures known as 
core 1, core 2, core 3, etc. The core 1 O-glycan is generated by 
the T-synthase, also known as the core 1     3  galactosyltransferase 
(Gal-T), which adds galactose to the Tn antigen to generate 
Gal    1-3GalNAc    1-Ser/Thr (T-antigen;   Ju et al., 2002a  ,  b  ). This is 
a key precursor for all core 1 and 2 mucin-type O-glycans in 
vertebrates and invertebrates. 
  The overall pathway of mucin glycosylation regulated by 
the branchpoint T-synthase function is developmentally impor-
tant because disruption of the   T-synthase   in mice is embryonic 
lethal (  Xia et al., 2004  ). Alternatively, another branchpoint 
  enzyme that utilizes the Tn antigen is the   C3GnT   (core 3     3- N -
acetylglucosaminyltransferase), specifi  cally expressed in the 
GI tract, which generates the disaccharide N-acetylglucosamine 
(GlcNAc)     1-3GalNAc    1-Ser/Thr. Disruption of the core 3 
O-glycan biosynthesis by eliminating   C3GnT   in mice is associated 
with increased susceptibility to colitis and colorectal tumors 
(  An et al., 2007  ). 
  We observed that some cells and tissues in patients with 
Tn syndrome or in some tumor cells lack T-synthase activity, 
although they have the T-synthase transcript, and express the Tn 
antigen, indicating a lack of branchpoint enzyme activity. In de-
ciphering the regulation of the T-synthase, we discovered that 
the T-synthase requires a unique and apparently client-specifi  c 
chaperone that we termed Cosmc (core 1     3 – Gal-T  specifi  c 
molecular chaperone), which is required for formation of active 
T-synthase (  Ju et al., 2002a  ,  b  ). Thus, the expression of the Tn 
antigen in patients with Tn syndrome and in human tumor cells 
results from mutations in   Cosmc   (  Ju and Cummings, 2005  ;   Ju 
et al., 2008  ). These discoveries prompted us to explore the molec-
ular nature of the potential chaperone function for Cosmc and 
its role in assisting the T-synthase in acquiring its active form. 
  Somatic mutations in   Cosmc   result in loss of T-synthase 
activity, apparently because of degradation of newly synthesized 
  R
egulatory pathways for protein glycosylation are 
poorly understood, but expression of branchpoint 
enzymes is critical. A key branchpoint enzyme is 
the T-synthase, which directs synthesis of the common 
core 1 O-glycan structure (T-antigen), the precursor structure 
for most mucin-type O-glycans in a wide variety of glyco-
proteins. Formation of active T-synthase, which resides in 
the Golgi apparatus, requires a unique molecular chaper-
one, Cosmc, encoded on Xq24. Cosmc is the only molecu-
lar chaperone known to be lost through somatic acquired 
mutations in cells. We show that Cosmc is an endoplasmic 
reticulum (ER)  –  localized adenosine triphosphate binding 
chaperone that binds directly to human T-synthase. Cosmc 
prevents the aggregation and ubiquitin-mediated degra-
dation of the T-synthase. These results demonstrate that 
Cosmc is a molecular chaperone in the ER required for 
this branchpoint glycosyltransferase function and show 
that expression of the disease-related Tn antigen can re-
sult from deregulation or loss of Cosmc function.
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and mouse T-synthase, the functions of other Cosmc orthologues 
have not been tested. 
 Interestingly, T-synthase orthologues were identifi  ed in both 
vertebrates and invertebrates such as   C. elegans   and   D. melano-
gaster  . Whereas T-synthase in some lower vertebrates has non-
conserved N-glycosylation sites, mammalian T-synthases lack 
N-glycosylation sites. In contrast, invertebrate T-synthases, as in 
  C. elegans   (  Ju et al., 2002a  ,   2006  ), contain multiple N-glycosylation 
sites, some of which appear to be conserved. Expression of in-
vertebrate T-synthase in insect cells does not require Cosmc for 
active protein formation (  Ju et al., 2006  ), which may suggest that 
the presence of N-glycosylation on invertebrate T-synthases may 
allow them to be folded in a Cosmc-independent pathway. 
  Human Cosmc localizes in the ER and 
T-synthase localizes to the Golgi apparatus 
in CHO K1 cells 
  To explore the subcellular localization of Cosmc and T-synthase, 
we prepared a C-terminal HA-tagged Cosmc (Cosmc-HA) 
and a C-terminal human protein C (HPC) 4  –  tagged T-synthase 
(T-synthase  –  HPC4). CHO K1 cells were transiently transfected 
with both constructs and immunostained with anti-HA and anti-
HPC4 antibodies. Anti-HA staining revealed a perinuclear pattern 
of expression for HA-Cosmc, and a merge of this image showed 
colocalization with calnexin, an ER marker (  Fig. 1, A  –  C  ). 
[ID]FIG1[/ID]  In con-
trast, anti-HPC4 staining revealed a punctate pattern for T-synthase 
that was coincident with the localization of      – mannosidase  II, 
a Golgi marker (  Fig.1, D  –  F  ). These results demonstrate that 
  human Cosmc localizes in the ER, whereas the T-synthase local-
izes to the Golgi apparatus. 
  We also stained with Alexa 488  –  labeled anti-HA (Fig. 
S3, green, available at http://www.jcb.org/cgi/content/full/jcb.
200711151/DC1) and Alexa 568  –  labeled Anti-HPC4 (Fig. S3, 
red) in the same cotransfected cells. Cosmc expression was peri-
nuclear, corresponding to ER localization, and T-synthase stained 
in a punctate pattern, corresponding to Golgi localization (Fig. S3), 
which is consistent with the results from   Fig. 1  . This result further 
demonstrates that Cosmc and T-synthase localize to different 
  cellular compartments. To confi  rm the localization of Cosmc in 
the ER and T-synthase in the Golgi apparatus, we stained human 
293T and MDA-MB-231 cells with rabbit polyclonal IgG pre-
pared against peptides from human Cosmc and T-synthase. 
The staining pattern for anti-Cosmc was similar to that for anti-
Calnexin (ER marker), whereas the staining pattern for anti  – 
T-synthase was similar to that for anti  –  mannosidase II (Golgi 
marker; unpublished data). These results are consistent with our 
observations using anti  –  epitope-tagged forms of Cosmc and 
T-synthase and further support the conclusion that Cosmc is primar-
ily localized in the ER and T-synthase is in the Golgi apparatus. 
  Cosmc is in heavy membrane fractions 
corresponding to the ER and T-synthase 
is in lighter membrane fractions 
corresponding to the Golgi apparatus 
  To further establish the localization of Cosmc in the ER, we per-
formed subcellular fractionation on sucrose gradients of 293T 
cells expressing full-length HPC4-Cosmc. T-synthase activity 
T-synthase via proteasome-dependent pathways ( Ju and Cummings, 
2002  ). Cosmc appears to be specifi  c for the T-synthase because 
expression of many other glycosyltransferase activities is un-
affected by loss of functional Cosmc (  Piller et al., 1990  ;   Ju 
and Cummings, 2002  ), and the only consequence in terms of 
glycoconjugate biosynthesis in cells accompanying loss of func-
tion in Cosmc is an increase in Tn and Sialyl Tn antigen ex-
pression. However, the precise location and function of Cosmc 
as a specifi  c molecular chaperone in T-synthase biosynthesis 
has not yet been elucidated. 
  In this paper, we report that Cosmc predominantly local-
izes in the ER and that the T-synthase is mainly localized in the 
Golgi apparatus. Importantly, Cosmc has ATP-binding activity 
that is consistent with its chaperone function for maturation of 
T-synthase. When the T-synthase is expressed in cells expressing 
a mutated Cosmc that results in loss of function or in insect cells 
that constitutively lack Cosmc, the enzyme aggregates and is 
subsequently degraded in the proteasome. Thus, Cosmc serves a 
unique function in the ER as the key posttranslational regulator 
for expression of the T-synthase and may represent a new type of 
chaperone functioning in regulating protein glycosylation. 
  Results 
  Human   Cosmc   and   T-synthase   are 
expressed coordinately in human tissue 
 To  defi  ne whether   Cosmc   and the   T-synthase   are coordinately ex-
pressed, we examined expression using Northern blot analysis of 
multiple human tissue samples.   Cosmc   is expressed in all tissues 
examined (Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200711151/DC1), with the highest expression in heart, 
skeletal muscle, kidney, liver, and placenta, which mirrors the 
expression of T-synthase (Fig. S1 B;   Ju et al., 2002a  ). The co-
ordinate expression of   Cosmc   and   T-synthase   in human tissues is 
consistent with a close relationship between these two proteins. 
    Cosmc   only exists in vertebrates and is 
highly conserved across species 
  Upon BLASTP searching in the National Center for Biotech-
nology Information database using human Cosmc, we identi-
fi  ed Cosmc orthologues in monkey, cow, mouse, rat, dog, bird, 
frog, and zebrafi  sh (Fig. S2, available at http://www.jcb.org/cgi/ 
content/full/jcb.200711151/DC1). No orthologues were found in 
  Caenorhabditis elegans  or  Drosophila melanogaster . All Cosmc 
orthologues are predicted to be type II transmembrane proteins, 
with a short N-terminal cytoplasmic domain (CD) and trans-
membrane domain (TMD) and a large C-terminal domain (Fig. S2). 
Human and primate Cosmc both have 318 aa, and there is only 
a single amino acid difference at V191I. In contrast, rodent 
Cosmc contains 316 aa and has   >  95% identity to human Cosmc 
but has a 2-aa gap between positions 33 and 34. These 2 aa are 
located at the beginning of the lumenal domain, which we show 
to be the functional domain of Cosmc. Frog Cosmc is a 317-aa 
protein with a gap in the sequence at position 33 compared with 
human. Zebrafi  sh Cosmc lacks 3 aa at the C terminus compared 
with human Cosmc, ending at position 315. Except for mouse 
Cosmc, which can act as a molecular chaperone for both human 533 LOCALIZATION AND FUNCTION OF COSMC   • Ju et al. 
encoding a soluble Cosmc with a C-terminal KDEL-ER reten-
tion sequence (HPC4-sCosmc-KDEL). Cosmc function is gen-
erally rate limiting for T-synthase activity (  Ju and Cummings, 
2002 ). Therefore, we cotransfected human 293T cells with  either 
HPC4-tagged full-length T-synthase alone or in addition to 
the Cosmc constructs. Endogenous T-synthase activity was only 
slightly promoted by HPC4-sCosmc, whereas coexpression 
with the HPC4-sCosmc-KDEL signifi  cantly increased T-synthase 
activity (  Fig. 2 A  ). 
[ID]FIG2[/ID]  The HPC4-sCosmc was mainly secreted into 
the media, whereas HPC4-sCosmc-KDEL was mainly retained 
in cells (  Fig. 2, B and C  ). These results show that in the ab-
sence of the CD, TMD, and an ER retention signal, Cosmc is 
secreted from cells. The slight promotion of T-synthase activity by 
HPC4-sCosmc may result from the small amount of protein that 
transiently resides in the ER during its biosynthesis. Importantly, 
both HPC4-sCosmc and HPC4-sCosmc-KDEL were functional 
in insect cells in rescuing T-synthase activity (unpublished data). 
As a control, we coexpressed T-synthase with sCosmc lacking 
its engineered signal sequence. That form of the protein, which 
was mainly recovered in fractions 12  –  14, corresponding to the 
fractions containing the Golgi enzyme marker     4 – Gal-T  ( Fig.  1  G ). 
In contrast, HPC4-Cosmc was recovered primarily in fractions 
6  –  9, corresponding to fractions containing the ER markers 
GRP78 and GRP94 ( Fig. 1 H ). These results indicate that Cosmc 
is primarily localized in the ER, whereas the T-synthase is pri-
marily localized in the Golgi apparatus, which is consistent with 
the immunofluorescent data (  Fig. 1, A  –  F  ). Some Cosmc was 
observed in light membrane fractions and may refl  ect a small 
fraction that shuttles between the ER and Golgi during potential 
retrieval, but this remains to be explored. 
  Soluble Cosmc with an engineered ER 
retention signal promotes T-synthase 
activity equivalently to wild-type Cosmc 
 To test whether the TMD of Cosmc was important to localization 
and function, we made two constructs: one encoding a soluble 
N-terminal HPC4-tagged Cosmc (HPC4-sCosmc) and the other 
  Figure 1.       Localization of human Cosmc and T-synthase  . (A  –  F) Immuno-
ﬂ  uorescent staining. CHO K1 cells cultured on chambered slides were tran-
siently transfected with Cosmc-HA or with T-synthase  –  HPC4 and stained 
with rat anti-HA IgG1 (green) and rabbit anti-calnexin IgG (red; A  –  C; bars, 
4   μ  m) or with mouse anti-HPC4 (green) and rabbit anti  –       -ManII (red; D  –  F; 
bars, 8   μ  m). (G and H) Sucrose gradient subcellular fractionation. 293T 
cells transiently transfected with HPC4-Cosmc were harvested and homog-
enized. The postnuclear supernatant (PNS) was loaded onto a sucrose 
gradient. After ultracentrifugation, 16 fractions (    0.6 ml/fraction) were 
collected and measured for both T-synthase and      4  –  Gal-T activity (G) and 
analyzed on Western Blot with anti-HPC4 and anti-KDEL (H).     
  Figure 2.       KDEL-tagged soluble form of Cosmc functions as wtCosmc and 
localizes in ER.   (A  –  C) Function of KDEL-tagged soluble form of Cosmc. 
293T cells were transiently transfected with plasmids encoding T-synthase  –
  HPC4, HPC4-sCosmc, HPC4-sCosmc-KDEL, and wtCosmc. Cell extracts 
were prepared and T-synthase activity was measured. Bar 1 represents a 
single value, bar 5 represents a mean of duplicate values with error bar 
shown, and the remaining bars represent a mean of triplicate values with 
error bars shown. The pink line indicates the endogenous level of T-synthase 
activity and the green line represents the activity after transfection of T-synthase 
alone (A). T-synthase and Cosmc in cell extracts and media were also 
analyzed by Western blot with anti-HPC4 (B and C). Black lines indicate 
that intervening lanes have been spliced out. (D  –  F) Localization of sCosmc-
KDEL. CHO K1 cells cultured on chambered slides transiently transfected 
with HPC4-sCosmc-KDEL were immunoﬂ  uorescently stained with anti-HPC4 
(green; D) and rabbit anti-calnexin IgG (red; E) and merged (F). The im-
ages were collected by confocal microscopy. Bars, 8   μ  m.     JCB • VOLUME 182 • NUMBER 3 • 2008  534
  Cosmc binds ATP 
  Many chaperones have ATP binding or ATPase activity, some with 
low affi  nity. Thus, we tested whether Cosmc has ATP binding 
  activity (  Itoh et al., 1995  ). Cosmc binds to ATP-Sepharose and 
can be eluted with ATP, although the protein does not bind well 
( Fig.  3 A ). 
[ID]FIG3[/ID]  In contrast, there was no signifi  cant binding of recom-
binant T-synthase to ATP-Sepharose. To further test whether 
Cosmc binds ATP directly, we performed photolabeling using 
8-azido     -[ 
32  P]ATP. Under ultraviolet exposure, the activated 
azido group directly cross-links to the peptide bond in the ATP 
binding region of Cosmc. Purifi  ed Cosmc, but not T-synthase, 
could be photo – cross-linked  with  8-azido     -[ 
32 P]ATP.  This  bind-
ing is specifi  c because it was signifi  cantly inhibited by excesses 
of cold ATP or GTP (  Fig. 3 B  ). Typically, either ATP or GTP can 
inhibit specifi  c ATP binding to molecular chaperones ( Csermely 
and Kahn, 1991  ;   Saira Mian, 1993  ;   Soti et al., 2002  ). These re-
sults demonstrate that Cosmc can bind ATP, which is similar to 
other chaperones, whereas T-synthase does not bind ATP. 
  Proteasome inhibitors cause accumulation 
of full-length T-synthase expression but fail 
to restore activity 
 Our previous study showed that T-synthase in Jurkat cells, which 
have a mutated   Cosmc  , accumulates upon treatment of the cells 
with lactacystin, a proteasome inhibitor (  Ju and Cummings, 
2002  ), suggesting that the degradation of misfolded T-synthase 
is targeted to the proteasome. Human carcinoma LSC cells 
would be expected to remain in the cytosol, had no effect on 
T-synthase activity either in mammalian cells or insect cells 
(unpublished data). Together, these results show that the CD 
and TMD of Cosmc are important for ER retention but are not 
important in chaperone function and that a C-terminal KDEL 
retention signal is as effective as the full-length protein in its 
chaperone function toward T-synthase. 
 To  confi  rm the localization of HPC4-sCosmc-KDEL in the 
ER, CHO K1 cells were transiently transfected and stained with 
Alexa  488 – labeled  HPC4  mAb.  The  HPC4-sCosmc-KDEL  was 
expressed in a perinuclear pattern that generally overlapped that 
of the ER marker calnexin, a transmembrane protein (  Fig. 2, D  –  F  ; 
  Wada et al., 1991  ;   Bergeron et al., 1994  ). Some lack of overlap 
in HPC4-sCosmc-KDEL expression and calnexin could result 
from the fact that the HPC4-sCosmc-KDEL is soluble, and some 
escapes to the Golgi and is secreted to media (  Fig. 2 C  ). 
  Cosmc contains a single potential site of N-glycosylation 
in its extreme C terminus at N313. Thus, we examined whether 
Cosmc was N-glycosylated. About one-third of HPC4-sCosmc and 
HPC4-sCosmc-KDEL were N-glycosylated (unpublished data), 
based on sensitivity to Peptidyl N-glycanase F, an enzyme that 
removes N-glycans. However, the normal transmembrane form of 
Cosmc was not detectably N-glycosylated because there was no 
change of electrophoretic mobility upon treatment with Peptidyl 
N-glycanase F (unpublished data). Ineffi  cient N-glycosylation of 
Cosmc may result from the fact that the potential N-glycosylation 
site is very close to the C terminus and is surrounded by acidic 
amino acids, which can impair the effi  ciency of N-glycosylation 
(  Whitley et al., 1996  ;   Nilsson and von Heijne, 2000  ). 
  To test whether N-glycosylation might be important to 
Cosmc function, we eliminated the N-glycosylation sequon by 
substitution of N313 to Q313 (N313Q-Cosmc). The chaperone 
function of N313Q-Cosmc was similar to that of the wtCosmc 
both in mammalian cells and insect cells (unpublished data). 
Thus, N-glycosylation of Cosmc is not required for its function, 
which is consistent with the fact that membrane form or full-
length Cosmc is ineffi  ciently N-glycosylated. 
  Cosmc itself does not have T-synthase 
activity 
  A previous study (  Kudo et al., 2002  ) indicated that the gene 
we initially reported as   Cosmc   (  Ju and Cummings, 2002  ) pos-
sibly encoded a second T-synthase (termed core 1     3 – Gal-T2), 
based upon some sequence identity (   22%)  with  T-synthase 
and apparent restoration of T-synthase activity in human Jurkat 
and LSC cells, which lack T-synthase activity. To clarify this 
point, we directly tested whether HPC4-sCosmc contained 
core 1      3  –  Gal-T activity. Cosmc lacked any detectable activity 
(Fig. S4, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200711151/DC1), whereas the soluble form of T-synthase 
contained high enzymatic activity (Fig. S4, A and B). Thus, Cosmc 
is not a second T-synthase. This is consistent with our recent 
analysis of mouse null mutants lacking the T-synthase, in which 
all T-synthase activity in the homozygous animals is missing 
(  Xia et al., 2004  ). Although Cosmc may have an evolutionary 
  sequence relationship to T-synthase, Cosmc functions as a chaper-
one, and not as a second T-synthase. 
  Figure 3.       Cosmc has ATP-binding activity  . (A) Hi-5 insect cells were in-
fected with Baculovirus encoding either Cosmc-HA or HPC4-sT-synthase plus 
wild-type Cosmc. Cells for Cosmc-HA and media from cell coexpressing 
HPC4  –  sT-synthase and wild-type Cosmc were harvested. The cell extracts 
and media were loaded on ATP-Sepharose column for chromatography 
and eluted with 50 mM ATP, respectively. The washes and eluates were 
analyzed by Western blot with anti-HA for Cosmc and anti-HPC4 for T-syn-
thase, as indicated. (B) HPC4-sCosmc and HPC4  –  sT-synthase (coexpressed 
with wtCosmc) were expressed in Hi-5 cells and puriﬁ  ed from the media. 
3   μ  g of Cosmc and T-synthase were photolabeled with 8-Azido      -[ 
32  P]ATP, 
analyzed on SDS-PAGE, and transferred to nitrocellulose membrane for 
radioautogram and Western blot with anti-HPC4. Black line indicates that 
intervening lanes have been spliced out.     535 LOCALIZATION AND FUNCTION OF COSMC   • Ju et al. 
In contrast, the steady-state level of T-synthase expression in 
LSB cells and activity of the protein remained unchanged. 
The truncated N-terminal peptide in LSC cells could result in 
a soluble T-synthase, which might be secreted into the media. 
Thus, the media was Western blotted with HPC4 mAb. There was 
no T-synthase detected in the media from LSC cells; however, a 
substantial amount of soluble T-synthase was secreted into the 
media from LSB cells (Fig. S5, available at http://www.jcb.org/
cgi/content/full/jcb.200711151/DC1). These data indicate that 
T-synthase synthesized in LSC cells is rapidly degraded by the 
proteasome because degradation was blocked by MG-132. Inter-
estingly, truncated T-synthase from LSC cells was the same size 
as the soluble form of T-synthase from LSB cell media, suggest-
ing that the truncation of T-synthase in LSC cells results from 
loss of the cytoplasmic and TMDs. 
  Truncated and full-length T-synthase from 
LSC cells localizes in rough ER, whereas 
T-synthase from LSB cells localizes in the 
Golgi apparatus 
 As shown in the previous section, T-synthase is a transmembrane 
protein localized in the Golgi, where it functions to synthesize 
  express the Tn antigen because of a lack of T-synthase activity 
(  Brockhausen et al., 1998  ), whereas LSB cells contain T-synthase 
activity, which implies that LSC cells lack Cosmc function. 
In other studies, we have found that LSC cells have dysfunctional 
Cosmc, caused by an insertional mutation in the   Cosmc   gene (  Ju 
et al., 2008  ). To investigate T-synthase in LSC cells, both LSC 
and LSB cells were stably transfected with C-terminal HPC4-
tagged full-length human T-synthase. Human recombinant 
T-synthase from LSB cell extract was enzymatically active and 
full length (    45 kD); however, T-synthase from LSC cell extracts 
was smaller (    38 kD), inactive, and there was a reduced protein 
expression (  Fig. 4 A  ), potentially caused by truncation or cleav-
age of the peptide from its N terminus by an unknown protease. 
[ID]FIG4[/ID]  
The low level of protein expression could be caused by either a low 
rate of protein expression or high rate of degradation. Interestingly, 
the   C. elegans   T-synthase, which does not require mammalian 
Cosmc, is expressed at equal levels recombinantly in both LSB 
and LSC cells (  Ju et al., 2006  ). Therefore, to explore whether 
degradation was involved in reduced T-synthase expression in 
LSC cells, the cells were treated with the proteasome inhibitor 
MG-132. In the presence of MG-132, more full-length T-synthase 
was recovered, although it was still inactive (  Fig. 4, A and B  ). 
  Figure 4.       Characterization of T-synthase ex-
pressed in LSC cells containing a dysfunctional 
Cosmc.   (A and B) MG-132 causes accumula-
tion of full-length T-synthase protein in LSC cells 
but failed to restore its activity. LSC and LSB 
cells stably expressing T-synthase  –  HPC4 were 
treated with 10   μ  M MG-132 for 12 h and har-
vested. Cell extract was made and one portion 
was used for measuring T-synthase activity (A), 
whereas the other portion was analyzed on 
SDS-PAGE (30   μ  g protein/lane) by Western 
blot with anti-HPC4 (B). Error bars represent 
  ±  1 SD from the mean. Black lines indicates 
that intervening lanes have been spliced out. 
(C  –  H) T-synthase expressed in LSC cells resides 
mainly in heavy membrane fractions (RER), 
whereas T-synthase from LSB cells is in light 
membrane fractions (Golgi). LSC and LSB cells 
as in A and B treated with 10   μ  M lactacys-
tin were homogenized and cell homogenate 
was fractionated on a sucrose gradient by ultra-
centrifugation. The fractions were collected 
and the activities of      4  –  Gal-T and T-synthase 
in fractions were determined (C). The fractions 
were also analyzed by Western blotting with 
anti-HPC4 (D  –  F), anti-20S proteasome      1-sub-
unit (G), and anti-KDEL (GRP78 and GRP94; H). 
In F, lane 2 represents the combination of 
fractions 1 and 2. (I  –  O) T-synthase expressed 
in LSC cells resides mainly in the lumen of the 
RER and was associated with GRP78. The cell 
PNS of LSC and LSB cells as in A and B was 
digested with 40   μ  g/ml trypsin in the presence 
or absence of 0.2% Triton X-100, and T-syn-
thase was analyzed under reducing SDS-PAGE 
by Western blotting with HPC4 mAb (I and J). 
As controls, calnexin and 20S proteasome      1-
subunit were also analyzed by Western blot-
ting with their respective antibody (K and L). 
T-synthase was puriﬁ  ed from LSC and LSB cells 
and Western blotted with anti-HPC4 (M) and 
anti-KDEL (GRP78; N). GRP78 in the cell ex-
tract corresponding to one-tenth of the material 
was detected to conﬁ  rm comparable starting 
amounts of material (O).     JCB • VOLUME 182 • NUMBER 3 • 2008  536
folded T-synthase in the ER of LSC cells might be a result of 
nonproductive association with known molecular chaperones. 
Many chaperones, such as calnexin/calreticulin and the UDP-
Glc:glycoprotein glucosyltransferase system, retain misfolded 
N-glycosylated proteins in the ER and help them fold correctly. 
However, this system cannot function with human T-synthase 
because it lacks N-glycans. Thus, we tested whether the GRP78 
or BiP machinery might associate with the inactive T-synthase 
in the ER of LSC cells. We conducted coimmunoprecipitation 
experiments in which the HPC4-tagged T-synthase expressed 
in LSC cells was purifi  ed, and this material was analyzed by 
Western blot to probe for coprecipitating chaperones. GRP78 
was coimmunoprecipitated with T-synthase from LSC cells but 
not from LSB cells (  Fig. 4, M  –  O  ). We did not detect HSP40 in 
this coprecipitation, but it is possible that it might be present 
because the antibody to HSP40 has low affi  nity. More compre-
hensive proteomic approaches will be needed to identify all the 
proteins that coprecipitate with inactive T-synthase. Neverthe-
less, these results show that inactive T-synthase in LSC cells is 
associated with a protein chaperone, but that association clearly 
cannot productively result in active folded enzyme. 
  T-synthase puriﬁ  ed from LSC cells treated 
with MG-132 is partially ubiquitinated 
  The results in the previous section show that misfolded T-synthase 
is degraded by an ER-associated degradation (ERAD) pathway, 
which usually requires ubiquitination. To probe whether the 
misfolded T-synthase is ubiquitinated, we performed a Western 
blot using anti-ubiquitin antibody against the affi  nity-purifi  ed 
full-length HPC4-tagged T-synthase from LSC cells treated 
with MG-132. The gels were intentionally overloaded to en-
hance detectability of ubiquitinated species. No ubiquitinated 
protein was detected in T-synthase purifi  ed from LSB cell ex-
tracts with or without MG-132 treatment (  Fig. 5, A and B  ). 
[ID]FIG5 [/ID]  
In contrast, a portion of the inactive T-synthase from LSC cells 
the core 1 structure (T-antigen). To explore the localization of 
the inactive T-synthase in LSC cells, we performed subcellular 
fractionation using sucrose gradient ultracentrifugation. Both 
LSC and LSB cells were transfected to express human T-synthase-
HPC4. Because of the low expression of T-synthase in LSC 
cells and less clear/organized images of the ER/Golgi in these 
tumor cells, we used sucrose gradient subcellular fractionation 
to localize Cosmc and the T-synthase in these cells. Subcellu-
lar fractionation studies, by Western blotting against the HPC4 
epitope, showed that both the protein and activity of T-synthase 
from LSB cells were in the light membrane fractions (fractions 
10  –  13) as is the Golgi marker      4  –  Gal-T (  Fig. 4, C and D  ). 
  Interestingly, truncated T-synthase from LSC cells was recov-
ered in the heavy membrane fractions (fractions 5  –  8;   Fig. 4 E  ), 
along with the ER markers 20S proteasome    1-subunit, GRP94, 
and GRP78 (  Fig. 4, G and H  ). In addition, the full-length 
T-synthase from LSC cells treated with lactacystin was mainly 
retained in heavy membrane fractions, with a small amount found 
in the light membrane fractions corresponding to the Golgi 
(  Fig. 4 F  ). These data support the conclusion that Cosmc func-
tions as an ER chaperone to assist the folding and/or acquisition 
of T-synthase activity. 
  Truncated T-synthase from LSC cells 
resides in the lumen of the rough ER 
associated with GRP78 
  The soluble, truncated, and inactive forms of T-synthase from 
LSC cells were recovered in heavy membrane fractions; how-
ever, they could be present in the lumen of the ER or associated 
with the cytosolic face of the ER membrane. To address this 
question, we treated the membranes with trypsin in the absence 
or presence of Triton X-100. We anticipated that the soluble 
truncated T-synthase in LSC cells might be associated with 
the proteasome on the cytosolic side of the ER. Unexpectedly, 
T-synthase from LSC cells, which was recovered in heavy ER 
membranes, was not cleaved by trypsin in the absence of Triton 
X-100 but was susceptible to trypsin action in the presence of 
Triton X-100 (  Fig. 4 I  ). As expected, T-synthase from LSB 
cells, which is Golgi localized, was insensitive to trypsin in the 
absence of Triton X-100 but was quantitatively lost by trypsin 
treatment in the presence of Triton X-100 (  Fig. 4 J  ). Calnexin, a 
type-I ER membrane protein containing a cytoplasmic tail of 
87 aa, was cleaved by trypsin with a shift of     10.5 kD and re-
tained the intact transmembrane and lumenal domains (  Fig. 4 K  ). 
In contrast, the 20S proteasome     1-subunit,  which  associates 
with the cytosolic side of the ER, was sensitive to trypsin (  Fig. 4 L  ). 
Similarly, calnexin and the 20S proteasome     1-sunbunit  from 
both of the cell types were digested by trypsin in the presence of 
Triton X-100 (  Fig. 4, I  –  L  ). T-synthase from LSC cell extracts 
(in the presence of Triton X-100) was decreased signifi  cantly 
even without trypsin treatment, which might be caused by par-
tial digestion by cellular (perhaps lysosomal) proteases. Collec-
tively, these results show that T-synthase from LSC cells, which 
is inactive, is mainly retained within the ER lumen. 
  In spite of the data in the previous paragraph, T-synthase 
lacks any described ER retention signals (  Gomord et al., 1999  ). 
Thus, we considered whether retention of the inactive and mis-
  Figure 5.       T-synthase expressed in LSC Cells is partially ubiquitinated  . LSC 
and LSB cells stably expressing T-synthase  –  HPC4 were treated with MG-
132 for 12 h and subsequently harvested. T-synthase from 200   μ  l of cell 
extract (500   μ  g of protein total) was puriﬁ  ed and analyzed by Western 
blot with anti-ubiquitin (A) ﬁ  rst, and then with anti-HPC4 (B) after stripping 
of the membrane.     537 LOCALIZATION AND FUNCTION OF COSMC   • Ju et al. 
treated with MG-132 was observed as high molecular mass spe-
cies. Importantly, high molecular mass species from LSC cells 
in the presence of MG-132 were stained with ubiquitin anti-
body. These results demonstrate that a fraction of the T-synthase 
that accumulates in LSC cells in the presence of a proteasome 
inhibitor is ubiquitinated. 
  T-synthase is present as disulﬁ  de-bonded 
covalent oligomers in the absence 
of Cosmc 
  Many molecular chaperones function to prevent protein oligo-
merization and subsequent degradation. To further investigate 
the nature of T-synthase synthesized in the absence of Cosmc, 
purifi  ed T-synthase from LSC and LSB cells were compared by 
Western blot under reducing conditions and after cross-linking 
with disuccinimidyl suberate (DSS). The T-synthase from LSB 
cells, which have normal wtCosmc, appears mainly as a mono-
mer under reducing conditions and as both monomers and dimers 
in nonreducing gels (  Fig. 6 A  ). 
[ID]FIG6[/ID]  In contrast, mainly the mono-
meric form of T-synthase is seen under reducing conditions 
from LSC cells (  Fig. 6 A  ). More striking is the presence of high 
molecular mass oligomeric forms of T-synthase in LSC cells ob-
served in nonreducing gels (  Fig. 6 A  ). These results demonstrate 
that in the absence of Cosmc, T-synthase cannot form dimeric 
enzyme but appears to form oligomeric complexes. 
  We explored the oligomeric state of T-synthase in the ab-
sence of Cosmc using the noncleavable cross-linker DSS. The 
T-synthase from LSB cells was mainly found in dimeric form in 
the presence of DSS (  Fig. 6 B  , lanes 7 and 8). However, most of 
the T-synthase from LSC cells was recovered as high molecular 
mass aggregates in the presence of DSS (  Fig. 6 B  , lanes 3 and 4). 
To confi  rm these results, we explored the oligomeric state of 
T-synthase generated in an insect expression system, which lacks 
a Cosmc orthologue. We examined T-synthase under reducing 
conditions in both intact Sf-9 cells and cell extracts treated with 
permeable DSS. In the absence of DSS or Cosmc, T-synthase is 
recovered primarily as a monomer in cells and extracts (  Fig . 6 C  , 
lanes 2 and 7). When coexpressed with Cosmc, we also recov-
ered T-synthase mainly as a monomer (  Fig. 6 C  , lanes 4 and 9). 
In contrast, treatment with DSS of cells expressing T-synthase 
but lacking Cosmc coexpression resulted in a quantitative shift 
of T-synthase to high molecular mass complexes (  Fig. 6 C  , 
lanes 3 and 8). However, coexpression of Cosmc and T-synthase 
rescued much of the T-synthase from cross-linking and a signif-
icant amount of T-synthase monomer was recovered (  Fig. 6 C  , 
lanes 5 and 10). These results indicate that in the absence of 
Cosmc, T-synthase appears in oligomeric and inactive complexes, 
whereas in the presence of Cosmc, T-synthase appears as a mono-
mer and dimer, demonstrating that Cosmc helps to prevent non-
productive oligomerization of T-synthase. 
  We also explored the effects of blocking proteasomal deg-
radation on the oligomeric state of T-synthase in LSC and LSB 
cells. When LSB cells were treated with lactacystin, there was 
little change in the amount of monomeric T-synthase recovered 
(  Fig. 6 B  , lane 9), and after DSS treatment of cells, there were 
increased amounts of the dimeric form, as expected because 
natural T-synthase is a homodimer, and a small amount of oligomers 
  Figure 6.       T-synthase from cells in the absence of a functional Cosmc is 
mainly in covalent oligomers.   T-synthase  –  HPC4 expressed in LSC and LSB 
cells treated with 10   μ  M lactacystin was afﬁ  nity puriﬁ  ed and analyzed 
on SDS-PAGE under reducing and nonreducing conditions and Western 
blotted with anti-HPC4 (A). Cell extracts were made and cross-linking was 
performed by adding 5 mM DSS. The recombinant T-synthase was puri-
ﬁ  ed and analyzed by Western blotting under reducing conditions (B). Sf-9 
cells infected with Baculovirus-expressing T-synthase-HPC4 or coinfected 
with Baculovirus encoding wtCosmc were harvested and one portion was 
made for cell extracts. The cell extracts and the other portion of intact cells 
were treated with DSS. T-synthase was puriﬁ  ed from the cell extracts and 
analyzed by Western blot with anti-HPC4 (C). Black line indicates that 
intervening lanes have been spliced out.     
form perhaps because of limited endogenous Cosmc (  Fig. 6 B  , 
lane 10). In contrast, treatment of LSC cells with lactacystin 
caused a larger increase in total T-synthase (  Fig. 6 B  , lane 5), JCB • VOLUME 182 • NUMBER 3 • 2008  538
Expression of the Tn and sialyl-Tn antigens in human tumors 
are associated with poor prognosis, including human breast car-
cinoma, and colorectal and esophageal cancer (  Springer, 1984  ; 
  Nakagoe et al., 2001  ;   Schietinger et al., 2006  ). However, until 
now the nature of Cosmc function in providing active T-synthase 
was unknown. We originally considered that Cosmc might be 
a   “  subunit  ”   of the T-synthase, but we found that purifi  ed active 
T-synthase from rat liver and purifi  ed recombinant soluble form 
of T-synthase from 293T cell media were fully active and devoid 
of Cosmc (  Ju et al., 2002a  ,  b  ). Thus, Cosmc is not a required co-
factor or subunit of active T-synthase enzyme. 
  Our studies demonstrate that Cosmc is a resident ER pro-
tein that binds ATP, whereas the T-synthase is a resident Golgi 
protein. In the absence of Cosmc, the T-synthase is retained 
in the ER lumen and accumulates as an enzymatically inactive 
oligomeric disulfi  de-bonded complex associated with GRP78. 
Proteins that are misfolded are eliminated from the ER by an 
ERAD pathway, in which misfolded proteins are targeted for 
reverse translocation out of the ER, where they are ubiqui-
tinated, and then disposed of in the cytoplasmic proteasome 
(  Ahner and Brodsky, 2004  ). The inactive T-synthase is sub-
jected to degradation by the ERAD pathway, as indicated by 
the presence of ubiquitinated T-synthase, which accumulates 
in the presence of proteasome inhibitors. The ER retention 
of Cosmc requires its transmembrane and cytosolic domains 
because soluble Cosmc is secreted from cells. However, soluble 
Cosmc engineered to contain a KDEL ER-retrieval signal is 
retained in the ER and functions as a chaperone for T-synthase. 
Human Cosmc and T-synthase are coordinately expressed in 
human tissues, indicating the close relationship between these 
with enhanced recovery of high molecular mass aggregates of 
T-synthase in DSS-treated cells (  Fig. 6 B  , lane 6). These results 
show that T-synthase in cells expressing functional Cosmc is 
primarily in active monomeric and dimeric forms, whereas in 
the absence of Cosmc, the T-synthase is partly degraded and re-
coverable in high molecular weight complexes, and no dimeric 
active forms of enzyme are present, indicating that proteolysis 
occurs in the context of the oligomeric complexes. 
  Cosmc directly interacts with T-synthase 
  Many molecular chaperones function to prevent protein oligo-
merization by directly interacting with their client proteins. 
To investigate the nature of Cosmc and T-synthase interaction, 
we purifi  ed soluble HPC4-tagged T-synthase and His-tagged 
Cosmc from Hi-5 cells and tested for their direct interaction 
in vitro. As a control, we used galectin-3, which would not be 
expected to bind Cosmc. After mixing Cosmc with either of 
these proteins, Cosmc was quantitatively captured by adsorp-
tion on Ni-NTA beads and eluted with imidazole. The input 
(loading), unbound, and bound materials were analyzed by 
Western blot with anti-Cosmc, anti-HPC4, or anti  –  galectin-3 
antibodies. Cosmc was quantitatively bound by Ni-NTA beads, 
whereas T-synthase did not bind to Ni-NTA beads (  Fig. 7, 
A and B  ). 
[ID]FIG7[/ID]  In contrast, from the mixture of Cosmc with T-synthase, 
a fraction of T-synthase coprecipitated with Cosmc (  Fig. 7, 
A and B  ). We tested whether this interaction was specifi  c to the 
client T-synthase using galectin-3 as a potential client. Galectin-3 
did not bind to Ni-NTA beads and also did not coprecipitate 
with Cosmc on Ni-NTA beads (  Fig. 7, C and D  ). These results 
show that Cosmc directly binds to T-synthase and that this inter-
action is specifi  c, supporting the conclusion that Cosmc is a 
specifi  c molecular chaperone for its client T-synthase and that 
they directly interact. 
  Discussion 
  Our interest in T-synthase and its regulation as a branchpoint 
enzyme arose from observations that the lack of T-synthase ac-
tivity, which leads to expression of the truncated Tn antigen, 
is correlated with several autoimmune diseases including IgA 
nephropathy (  Allen et al., 1997  ) and Tn-Syndrome (  Berger, 1999  ). 
In addition, the Tn and sialyl-Tn antigen are recognized as tumor-
associated antigens in mucins and other glycoproteins from 
many human tumors (  Springer, 1984  ;   Nakagoe et al., 2001  ; 
  Schietinger et al., 2006  ). In examining human Jurkat cells that 
lacked T-synthase activity, we found that expression of the 
T-synthase transcript was normal but, surprisingly, active forms 
of recombinant T-synthase could not be expressed in cells. This 
led to our fi  nding of Cosmc as a required molecular chaperone 
for active T-synthase formation and the fi  nding that the X-linked 
  Cosmc   gene [Xq24] is mutated in cells lacking T-synthase activ-
ity (  Ju and Cummings, 2002  ). Thus, acquired somatic or poten-
tially inherited mutations in   Cosmc   could account for the defects 
in core 1 O-glycan biosynthesis and expression of Tn antigen. 
We recently showed that mutations in   Cosmc   are associated with 
Tn antigen expression in patients with Tn syndrome (  Ju and 
Cummings, 2005  ) and in human tumor cells (  Ju et al., 2008  ). 
  Figure 7.       Cosmc directly interacts with T-synthase.   The N-terminal His-
tagged soluble Cosmc were expressed in Hi-5 insect cells. The human 
N-terminal HPC4 epitope-tagged soluble T-synthase was expressed by co-
transfecting WT Cosmc in Hi-5 insect cells. Proteins were puriﬁ  ed directly 
from the media and used in coprecipitation experiments to test physical as-
sociation. Galectin-3 was used as a negative control for speciﬁ  city. Cosmc, 
T-synthase, Cosmc and T-Synthase, Galectin-3, Cosmc and Galactin-3 were 
incubated with Ni-NTA Superﬂ  ow. Ni-NTA Superﬂ  ow beads were washed 
and proteins were eluted and analyzed by Western blot with mAb to the 
HPC4, anti-Galectin-3, and anti-Cosmc. Cosmc interactions with T-synthase 
were determined (A and B). As a control, Cosmc and Galectin-3 inter-
actions were determined (C and D). Black line indicates that intervening 
lanes have been spliced out. L, loading; U, unbound; B, bound.     539 LOCALIZATION AND FUNCTION OF COSMC   • Ju et al. 
binds directly to ATP, thus indicating that Cosmc is a chaperone. 
In other experiments, when we purifi  ed the T-synthase from rat 
liver microsomes, which included the ER and Golgi compart-
ments, we found that both Cosmc and HSP40 copurifi  ed in early 
steps with the T-synthase (unpublished data). Although this fur-
ther supports a role for Cosmc as a T-synthase chaperone, it also 
indicates that HSP40 could be a cochaperone for Cosmc as it is 
for HSP70 (  Kleizen and Braakman, 2004  ). 
  In order for the misfolded T-synthase to be ubiquitinated 
by ubiquitination system, it must be retrotranslocated from the 
lumen back to the cytosol. However, little is known about the 
mechanisms of retrotranslocation for type II membrane proteins 
and how such unfolded proteins that accumulate in the ER are 
degraded by ERAD pathway. The degradation of T-synthase, 
the fi  rst identifi  ed enzyme with a defi  ciency in its ER chaperone 
protein that leads to disease, may provide a novel system to ex-
plore these pathways. 
  Thus, Cosmc represents a protein-specifi  c quality control 
factor and joins a growing number of such chaperones in the 
ER (  Hendershot and Bulleid, 2000  ;   Ellgaard and Helenius, 
2003  ). Cosmc is not a T-synthase subunit, lacks glycosyltrans-
ferase activity, and, among glycosyltransferases, it is only known 
to associate with the inactive T-synthase. We noted that Cosmc 
does not associate with fully folded T-synthase (  Ju and Cummings, 
2002  ), but it can be coimmunoprecipitated with a subset of 
T-synthase proteins, likely representing folding intermediates 
in the pathway to fully active enzyme. Most importantly, we 
have shown that purifi  ed recombinant Cosmc can directly in-
teract with purifi  ed T-synthase. As expected, only a small frac-
tion of recombinant T-synthase coprecipitated with purified 
recombinant His-tagged Cosmc, which could result from the 
possibility that only a fraction of purifi  ed recombinant T-synthase 
might be in unfolded state upon purification. This fraction 
therefore transiently interacts with active recombinant His-
tagged Cosmc, supporting the fact that Cosmc is an ER molec-
ular chaperone, but this issue will require extensive studies, 
including exploring the role of ATP in these interactions. Loss-
of-function of Cosmc results in the formation of misfolded aggre-
gates of T-synthase polypeptide, which would be predicted to 
be retrotranslocated back to the cytosol where ubiquitination 
two proteins. Active T-synthase cannot be expressed without 
the presence of functional Cosmc (  Ju and Cummings, 2002  ). 
More importantly, purifi  ed recombinant Cosmc directly inter-
acts with purifi  ed recombinant T-synthase ( Fig. 7 ). Thus, Cosmc 
is an ER-localized molecular chaperone that prevents degrada-
tion and aggregation of mammalian T-synthase, and the overall 
proposed pathway is shown in   Fig. 8  . 
[ID]FIG8[/ID]  It is important to note that 
Cosmc itself does not have any T-synthase activity, which is in 
contrast to a previous study that erroneously concluded that the 
  Cosmc   gene encoded a second core 1     3 – Gal-T  (T-synthase)  in 
humans named C1Gal-T2 (  Kudo et al., 2002  ). The T-synthase 
activity is encoded by a single gene, which is consistent with 
our studies in this paper showing that loss of Cosmc function is 
associated with a complete loss of T-synthase activity, that dele-
tion of   T-synthase   in mice eliminates all T-synthase activity and 
results in embryonic death (  Xia et al., 2004  ), and that mutations 
in   Cosmc   are associated with loss of T-synthase in patients with 
Tn syndrome (  Ju and Cummings, 2005  ). 
  The T-synthase is not a glycoprotein and has no canonical 
motifs for N-glycosylation, which is in contrast to most glycosyl-
transferases. Thus, the T-synthase, unlike other newly synthe-
sized glycoproteins in the ER, cannot interact with the known 
quality control systems composed of several lectin-based chaper-
ones, such as the calnexin/calreticulin system, and other glycan-
recognizing or modifying proteins ( Ruddock and Molinari, 2006 ; 
  Schroder, 2006  ;   Otsu and Sitia, 2007  ). The absence of such inter-
actions may underscore the molecular function of Cosmc in 
specifi  cally preventing oligomerization and inactivation of the 
T-synthase and provides the fi  rst specifi  c evidence for the quality 
control of nonglycosylated protein folding in the ER. 
  It is interesting that although the ER contains many cha-
perones that can promote proper protein folding, in the absence 
of Cosmc these chaperones are not successful in promoting 
folding of the T-synthase. We found that GRP78 (BiP) could be 
coimmunoprecipitated with inactive T-synthase generated in the 
absence of Cosmc. GRP78 is known to associate with unfolded 
proteins in the ER to aid in their exit (  Kleizen and Braakman, 
2004  ;   Ni and Lee, 2007  ). The inactive oligomers of T-synthase 
accumulate within the ER in the absence of Cosmc and reside 
within disulfi  de-bonded complexes. We also found that Cosmc 
  Figure 8.       Working model for Cosmc function.   
Human Cosmc is localized predominantly in 
the ER where it interacts with the nascent poly-
peptide of human T-synthase. Cosmc, along with 
other ER chaperones such as HSP70 (BiP)/
HSP40 and protein disulﬁ  de isomerase (PDI), 
assists its folding properly. Native T-synthase, 
which occurs mainly as a homodimer, exits 
to the Golgi apparatus, where it functions in 
synthesizing core 1 O-glycans (T-antigen). When 
Cosmc is mutated and dysfunctional, the nascent 
polypeptides of T-synthase form inactive aggre-
gates or oligomers, which are associated with 
GRP78 (BiP), and subsequently proceed to the 
ERAD pathway where they are retrotranslocated 
from the ER to the cytosol, ubiquitinated, and 
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of pcDNA3.1(+) containing wild type Cosmc (  Ju et al., 2002a  ). A con-
struct encoding a soluble N-terminal HPC4 epitope-tagged Cosmc (HPC4-
sCosmc) was made using the similar strategy to making soluble N-terminal 
HPC4 epitope-tagged T-synthase (HPC4  –  sT-synthase;   Ju et al., 2002a  ). 
The construct in pcDNA3.1(+) or pVL1393 with an HPC4-epitope tag was 
fused inframe with the lumenal domain of Cosmc. HPC4-sCosmc with the 
KDEL-retrieval signal at its C terminus (HPC4-sCosmc-KDEL) was constructed 
using PCR and subcloning into pcDNA3.1(+). The PCR primers are listed 
in   Table I  . 
[ID]TBL1[/ID]  
  The construct for expression of a soluble N-terminal 6  ×   His-tagged 
Cosmc was prepared using the following strategy. The N-terminal cytoplas-
mic and TMDs of Cosmc were replaced with transferrin N-terminal signal 
sequence followed by 6  ×   His tag. The lumenal domain of Cosmc was pre-
pared by the digestion of full-length   Cosmc   cDNA in pcDNA3.1(+) with 
BsmI  –  XbaI. The Vector with pVL1393 backbone and transferrin N-terminal 
signal sequence was obtained by digestion of the plasmid encoding hu-
man soluble T-synthase with EcoNI  –   XbaI. The DNA oligos (IDT [Integrated 
DNA Technologies]) encoding 6  ×   His coding sequence with EcoNI and 
BsmI at each site were synthesized and would ﬁ  ll in the gap between the 
EcoNI site from the vector and the BsmI site from the   Cosmc   fragment. The 
DNA oligos were the following: sense strain, 5     -CCCATCACCATCACCAT-
CACGACGATGACGATAAGAGGATTGGTCATGGAAATAGAATGCA-3     ; 
and the complementary strain, 5     - CATTCTATTTCCATGACCAATCCTCT-
TATCGTCATCGTCGTGATGGTGATGGTGATGG-3      . Then the vector fragment, 
the annealed oligos, and the   Cosmc   fragment were ligated and the con-
struct was made and conﬁ  rmed by sequencing. 
  Cell culture 
  293T, CHO K1, LSC, and LSB cells were cultured in DME plus 10% FBS at 
37  °  C in 5% CO  2  . Sf-9 cells were cultured in TNM-FH, whereas Hi-5 cells 
were cultured in Ex-Cell 405 media at 27  °  C. 
  Transfection and glycosyltransferase activity 
  Mammalian cells were transfected with Fugene6 transfection reagent and 
insect cells were transfected with a BaculoGold Transfection kit (  Ju and 
Cummings, 2002  ). T-synthase activity was measured using GalNAc-     -phenyl 
as the acceptor (  Ju et al., 2002b  ).      4  –  Gal-T activity was measured using 
pNP-     -S-GlcNAc as the acceptor (  Kawar et al., 2002  ). 
  Immunoﬂ  uorescent staining of CHO K1 cells 
  CHO K1 cells were cultured on a chambered slide and transiently trans-
fected with the expression constructs using Fugene 6 transfection reagent 
according to the manufacturer  ’  s protocol. At 48 h after transfection, cells 
were washed with PBS and ﬁ  xed with 4% PFA on ice for 45 min and per-
meabilized with 0.1% Triton X-100 for 30 min on ice. After blocking with 
1% BSA in PBS for 1 h at RT, the cells were incubated with primary anti-
bodies for 1 h at RT. The cells were washed with PBS three times and 
incubated with Alexa Fluor  –  labeled secondary antibodies at RT for 1 h. 
In some cases, the transfected cells were stained with Alexa Fluor  –  labeled 
primary antibodies directly, as indicated in the ﬁ  gures. Cells were then 
washed four times with PBS and mounted with Prolong Antifade Media 
(Invitrogen). After drying at RT for 12  –  16 h, cells were visualized on a 
confocal microscope (TCS NT; Leica) at RT under 40  ×   Plan Fluotar 1.0 NA 
oil immersion or 100  ×   Plan APO 1.4 NA oil immersion objective lenses. 
The images were maximum projection collected with a pinhole of 1 using 
0.5-  μ  m step size. Images were analyzed using the TCS and Volocity soft-
ware (Leica). 
  Preparation of cell extracts 
  Cell extracts were prepared as previously described (  Ju and Cummings, 
2002  ). Protein concentration was determined by BCA assay according to 
manufacturer  ’  s protocol. 
occurs, and the ubiquitinated protein is then degraded in the 
proteasome, as shown in the model (  Fig. 8  ). Overall, our study 
shows that Cosmc is a key regulator of the expression of functional 
T-synthase, which represents a novel mechanism for controlling 
a branchpoint glycosyltransferase in O-glycan biosynthesis. 
  Materials and methods 
  Materials 
  GalNAc-     -phenyl, UDP-Gal, GlcNAc-     -S-pNp, and ATP-Sepharose were 
obtained from Sigma-Aldrich. UDP-6-[ 
3  H]Gal (40  –  60 Ci/mmol) was ob-
tained from American Radiolabeled Chemicals, Inc. Human embryonic 
kidney cell line (HEK293T), Chinese hamster ovary cells (CHO K1), and 
insect cells (Hi-5 and Sf-9) were obtained from American Type Culture Col-
lection. Human colon carcinoma cell lines LSC and LSB were provided by 
S. Itzkowitz (Mount Sinai School of Medicine, New York, NY). Sep-Pak 
C18 Cartridges were obtained from Waters Corporation. Restriction en-
zymes were obtained from New England Biolabs, Inc. FuGENE6, Taq 
DNA polymerase, and rat anti-HA mAb were obtained from Roche. TNM-FH 
and EX-Cell 405 media, BaculoGold Transfection kit, vector pVL1393, 
mouse anti  –  human calnexin mAb (IgG1), mouse anti-  –  human HSP40, 
and anti-ubiquitin mAb (IgG1) were purchased from BD Biosciences. 
  Galactin-3 antibody was purchased from Santa Cruz Biotechnology, Inc. 
Rabbit anti  –  human calnexin antiserum and mouse anti-KDEL (GRP78 and 
GRP94) mAb (10C3) were purchased from Assay Designs. Alexa Fluor  –
  labeled secondary antibodies were purchased from Invitrogen. Peroxidase-
labeled secondary antibodies were obtained from KPL. Proteasome 
inhibitors MG-132 and lactacystin and rabbit anti  –  human proteasome 
20S     -type1 subunit (IgG) were purchased from EMD. Vector pcDNA3.1(+), 
PCR TOPO4 cloning kit, SuperScript One-Step RT-PCR kit and SDS-PAGE 
gels were obtained from Invitrogen. Ni-NTA Superﬂ  ow, Plasmid Puriﬁ  -
cation kit, and QIAquick Gel Extraction kits were obtained from QIAGEN. 
8-Azido      -[ 
32  P]ATP was purchased from Afﬁ   nity Labeling Technologies. 
Chemiluminescent Substrate, BCA protein assay kit, DSS, and UltraLink 
Support Media were purchased from Thermo Fisher Scientiﬁ  c. Rabbit anti  –
  mannosidase II antibody was provided by K. Moremen (University of   Georgia, 
Athens, GA). 
  Northern blot of human Cosmc and T-synthase 
  Human 12-lane multiple tissue Northern blot (Clontech Laboratories, Inc.) 
was incubated with  
32  P-labeled probes for full length of human Cosmc 
(970 bp) as previously described (  Ju et al., 2002a  ) at 68  °  C overnight 
  using PerfectHyb solution (Sigma-Aldrich). After washing, the blot was ex-
posed to BioMax x-ray ﬁ  lm (Kodak) for 36 h and developed.      -Actin in the 
same blot was probed with  
32  P-labeled human Actin cDNA as previously 
described (  Ju et al., 2002a  ). 
  Preparation of expression constructs 
  A construct encoding C-terminal HA-tagged Cosmc (Cosmc-HA) was made 
by introducing HA-epitope (YPYDVPDYA) into wild-type Cosmc at its C ter-
minus by PCR. The product was cloned into PCR3.1. The insert was cut 
with BamHI (partially)  –  XbaI and cloned into pcDNA3.1(+) or pVL1393. 
The construct expressing C-terminal HPC4 epitope-tagged T-synthase was 
made as previously described (  Ju and Cummings, 2002  ). A construct en-
coding N-terminal HPC4-tagged Cosmc (HPC4-Cosmc) was made using a 
similar strategy to Cosmc-HA. The HPC4 epitope tag was introduced into 
the N terminus of Cosmc by PCR. The PCR product was digested with 
BamHI and ligated with the vector fragment generated by BamHI digestion 
  Table I.     PCR primers used for making expression constructs 
Constructs Forward primer Reverse primer
Cosmc-HA 5     -GCGGATCCACCATGCTTTCTGAAAGCAGC 
   TCCTTTTTG-3    
5     -GCTCTAGACTAAGCGTAGTCTGGGACGTCGTATGGGTAG 
   TCATTGTCAGAACCATTTG-3      (containing HA-tag sequence)
HPC4-Cosmc 5     -GCGGATCCACCATGCTTGAGGACCAGGTGGA 
   CCCCAGGCTGATCGACGGCAAGATGCTTTCTGA 
   AAGCAGCTCC-3      (containing HPC4-tag sequence)
5     -GGTCTCCAGATTTTATAGTGTGGC-3    
HPC4-sCosmc-KDEL 5     -TCCTTGCACGCCCCACTACG-3    5     -GCTCTAGAGTTCATCTTTGTCATTGTCAGAACCATTTG-3       
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DSS and 1% DMSO at RT for 30 min. The other portion of Sf-9 cells was 
treated with 5 mM DSS at RT for 30 min and the cell extracts were made 
as previously described. The reaction was quenched by adding 50 mM 
Tris-HCl, pH 7.5. After adding 1 mM CaCl  2   to all cell extracts, the T-synthase  –
  HPC4 was puriﬁ  ed and analyzed on Western blot with anti-HPC4. 
  In vitro Cosmc and T-synthase coprecipitation 
  Approximately 2   μ  g each of His-tagged soluble Cosmc, HPC4-tagged sol-
uble T-synthase, and soluble Galectin-3 (provided by S. Stowell, Emory 
University, Atlanta, GA) were used. His-Cosmc and HPC4-T-synthase were 
mixed in buffer (5 mM Tris-HCl and 30 mM NaCl, pH 7.85). Similarly, 
His-Cosmc and Galectin-3 were mixed. For controls, His-Cosmc and 
HPC4  –  T-Synthase were individually prepared in buffer. All preparations 
were incubated at RT (    23  °  C) for 25 min. One-ﬁ  fth of each mixture was 
allocated for input (loading). The remaining part was diluted 25  ×   with 
Ni-NTA washing buffer (50 mM imidazole, 50 mM NaH  2  PO  4  , 300 mM 
NaCl, and 0.1% Triton X-100, pH 7.8). 20   μ  l Ni-NTA Superﬂ  ow beads 
(QIAGEN) were added to the Ni-NTA washing buffer. Proteins were incu-
bated with beads overnight while rotating at 4  °  C. The beads were col-
lected using bench centrifugation and the beads were washed ﬁ  ve times 
with 400   μ  l Ni-NTA washing buffer. The bead-bound material was eluted 
ﬁ  ve times with 20   μ  l of elution buffer (50 mM NaH  2  PO  4  , 300 mM NaCl, 
250 mM imidazole,0.1% Triton X-100). Input, unbound, and bound frac-
tions (in equal proportions) were electrophoresed on an SDS/PAGE (4  –  20%) 
and transferred to nitrocellulose membrane (Bio-Rad Laboratories). After 
blocking with 1% milk, Western blots were performed, first for HPC4  –
  T-synthase and Galectin-3, using 4 ml of 4   μ  g/ml mAb to HPC4 and 4 ml 
of 0.2   μ  g/ml of antibody to Galectin-3. The membranes were incubated 
for 1 h at RT. For HPC4 blotting, the membrane was washed ﬁ  ve times 
with 20 mM Tris-HCl, 300 mM NaCl, and 1 mM CaCl  2  , pH 7.2. For 
Galectin-3, the membrane was washed ﬁ  ve times with 20 mM Tris-HCl, 
300 mM NaCl, and 0.05% Tween-20, pH 7.2. After washing, the mem-
branes were incubated with 4 ml of 0.17 ng/ml HRP-conjugated goat 
anti  –  mouse IgG at 23  °  C for 45 min. Membranes were washed ﬁ  ve times 
with 20 mM Tris-HCl, 300 mM NaCl, and 1 mM CaCl  2  , pH 7.2, and in-
cubated with 3 ml of SuperSignal West Pico Chemiluminescent Substrate 
at RT for 1 min. The blot was exposed to ﬁ  lm (Denville Scientiﬁ  c, Inc.) for 
1 min, and developed by autoradiography. The membranes were stripped 
by washing with 2% SDS and 1% 2-mercaptoethanol in deionized water 
for 30 min, followed by washing three times with 20 mM Tris-HCl and 
300 mM NaCl, pH 7.2. The membranes were blocked with 1% milk and 
washed three times with 20 mM Tris-HCl and 300 mM NaCl, pH 7.2. 
Membranes were incubated with polyclonal chicken IgG against Cosmc 
using 4 ml of 0.2   μ  g/ml antibody for 1 h. Membranes were washed ﬁ  ve 
times with 20 mM Tris-HCl and 300 mM NaCl, pH 7.2, and incubated 
with 4 ml of 0.17 ng/ml HRP-conjugated goat anti  –  chicken IgG at 23  °  C 
for 45 min. Membranes were washed with 20 mM Tris-HCl and 300 mM 
NaCl, pH 7.2, and developed accordingly. 
  Online supplemental material 
  Fig. S1 shows that human   Cosmc   is coordinately transcribed with human 
  T-synthase   in Northern blot. Fig. S2 shows that protein sequences of Cosmc 
are highly conserved across species. Fig. S3 shows that Cosmc and T-synthase 
localize in different cellular compartments. Fig. S4 shows that Cosmc 
itself does not have any T-synthase activity. Fig. S5 shows that truncated 
T-synthase protein in LSC cells is not secreted into the media. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200711151/DC1. 
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